# SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
> **ANDA087655** · Abbreviated New Drug Application (Generic) · Sponsor: VANGARD · Approved 1981-12-14
## Drug
- **FDA Application Number:** ANDA087655
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
- **Generic name:** Hydrochlorothiazide
- **Active ingredients:** HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** VANGARD
- **First approval:** 1981-12-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=087655)
---
*AI Analytics · CC0 1.0*